Overview

Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This 52 week long study evaluates the effectiveness of aripiprazole versus risperidone in treating people with first-episode schizophrenia. Patients who do not improve with these medications receive clozapine as their third medication trial.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Aripiprazole
Risperidone